Full name
PROPHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.38.Z - Wholesale trade of other food products
10.86.Z - Production of homogenized food products and diet food
10.89.Z - Production of other food products, not elsewhere classified
46.39.Z - Wholesale trade of non-specialized food, beverages, and tobacco products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.11.Z - Non-specialized retail trade with a predominance of food, beverages, or tobacco products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.91.Z - Intermediary retail sale, non-specialized
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | ||||
Gross profit (loss) | 0,2 | 0 | 0 | -9,7 |
EBITDA | 0,3 | 0,1 | 0,1 | -19,9 |
Short time liabilities | 2 | 1,2 | 1 | -13,9 |
Other operating costs | ||||
Equity capital | 3,1 | 3,2 | 3 | -5,1 |
Operating profit (EBIT) | 0,2 | 0 | 0 | 13,5 |
Assets | 5,5 | 4 | 4,1 | 1 |
Net profit (loss) | 0,1 | 0 | 0 | -64,7 |
Cash | 0,3 | 0,1 | 0,1 | -30,7 |
Net income from sale | 14,1 | 12,5 | 11,3 | -9,8 |
Liabilities and provisions for liabilities | 2,3 | 1,2 | 1,1 | -12,4 |
Working assets | 5 | 3,5 | 3,5 | 0 |
Other income costs | ||||
Depreciation | 0,1 | 0,1 | 0 | -37,8 |
% | % | % | p.p. | |
Profitability of capital | 4,1 | 1,1 | 0,4 | -0,7 |
Equity capital to total assets | 57,4 | 71,9 | 73,4 | 1,5 |
Gross profit margin | 1,5 | 0,3 | 0,3 | 0 |
EBITDA Margin | 2 | 0,7 | 0,6 | -0,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 51 | 35 | 34 | -1 |
Current financial liquidity indicator | ||||
Net dept to EBITDA |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane